newsfilter
← Latest News
GlobeNewswire·

Sensei Biotherapeutics to Present at Upcoming Conferences

BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer